Atrial Fibrillation History Feature vs Reveal LINQ
AI Verdict
Choose Atrial Fibrillation History Feature if…
Choose Apple's AFib History Feature if you are a diagnosed AFib patient seeking to actively understand how lifestyle factors influence your condition and want to track retrospective AFib burden trends. This tool empowers you to engage with your heart health data, identify potential triggers, and easily share comprehensive summaries with your healthcare provider for informed discussions on ongoing management.
View Atrial Fibrillation History Feature →Choose Reveal LINQ if…
Choose Medtronic Reveal LINQ if you require long-term, continuous, and highly accurate cardiac monitoring for diagnostic purposes, particularly when symptoms are infrequent or elusive. This implantable device is ideal for identifying underlying arrhythmias in cases of unexplained syncope, cryptogenic stroke, or when a definitive diagnosis of AFib or other cardiac events is critical over an extended period.
View Reveal LINQ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Atrial Fibrillation History Feature | Reveal LINQ |
|---|---|---|
| Deployment | Mobile App | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. |
| BAA Available | No AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | No AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Atrial Fibrillation History FeatureTool A (Apple AFib History) leverages familiar consumer technology (Apple Watch and iPhone), making it highly accessible and intuitive for patients to track their AFib history and understand lifestyle impacts. Tool B, while offering advanced diagnostic capabilities, requires a minimally invasive surgical procedure for implantation, making its initial 'usability' for the patient a more significant medical event.
Clinical Value
Reveal LINQTool B (Reveal LINQ) provides continuous, long-term (up to three years) diagnostic-grade ECG monitoring with AI algorithms to accurately detect and diagnose various cardiac arrhythmias, including AFib, which is crucial for initial diagnosis and management of serious conditions. Tool A offers valuable retrospective insights into AFib burden and lifestyle correlations for *diagnosed* users, aiding in self-management but not providing primary diagnostic capabilities.
Pricing & Value
Atrial Fibrillation History FeatureTool A (Apple AFib History) is included as a feature with the purchase of a compatible Apple Watch, offering transparent and accessible pricing for the individual consumer. Tool B's pricing is not publicly disclosed and is typically negotiated with healthcare providers, making its direct cost less transparent for the end-user, though its value lies in its advanced diagnostic capabilities often covered by insurance.
Enterprise Readiness
Reveal LINQTool B (Reveal LINQ) is designed as a medical device for clinical use, with explicit HIPAA compliance and a system (CareLink network, clinician app) for secure data transmission and integration into healthcare workflows, making it suitable for enterprise deployment. Tool A, while providing valuable patient data, lacks formal HIPAA compliance and a BAA, and its data export is primarily a PDF for individual physician review rather than direct EHR integration.
Innovation
Reveal LINQTool B (Reveal LINQ) demonstrates significant innovation in medical device technology with its miniaturization (world's smallest insertable cardiac monitor), long-term continuous monitoring capabilities, and the integration of AccuRhythmu2122 AI algorithms for enhanced diagnostic accuracy and reduced false alerts. Tool A innovates by bringing clinically relevant retrospective AFib insights to a widely adopted consumer wearable, focusing on patient engagement and lifestyle correlation.
Support & Docs
Reveal LINQTool B (Reveal LINQ), as a critical implantable medical device, is backed by Medtronic's specialized support infrastructure, offering comprehensive technical documentation, training, and dedicated support for healthcare professionals and patients. Tool A relies on Apple's general consumer support channels and documentation, which, while extensive, are not tailored for the specific clinical and technical support needs of a medical device.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Atrial Fibrillation History Feature | Reveal LINQ |
|---|---|---|
| Name | Atrial Fibrillation History Feature | Reveal LINQ |
| Company | Apple | Medtronic |
| Core Functionality / Monitoring Type | Retrospective AFib burden estimation (weekly percentage), tracking and trending AFib burden over time, visualization of lifestyle factors impacting AFib. Not intended for real-time AFib detection or continuous monitoring. | Continuous ECG monitoring for up to three years, automatic and patient-activated event recording, detection and diagnosis of cardiac arrhythmias including atrial fibrillation, cryptogenic stroke, and unexplained syncope. |
| Monitoring Duration | Retrospective (weekly percentage), tracking over time. Not continuous. | Up to three years (continuous ECG monitoring). |
| AI Algorithms Used | Not specified | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and pause). |
Videos
Demos, reviews, and walkthroughs featuring Atrial Fibrillation History Feature and Reveal LINQ.